Pure Bioscience Stock Price Patterns

Intrinsic Valuation Low Real High 0.00 0.04 8.21 Details

Naive Forecast Low Next High 0.0009 0.05 8.22 Details

Bollinger Band Projection (param) Lower Middle Band Upper 0.04 0.05 0.06 Details

Pure Bioscience After-Hype Price Density Analysis

Pure Bioscience Estimiated After-Hype Price Volatility

Pure Bioscience OTC Stock Price Outlook Analysis

Notes

Pure Bioscience Hype Timeline

Pure Bioscience is at this time traded for 0.04. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Pure is projected to increase in value after the next headline, with the price projected to jump to 0.05 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is projected to be 11.11%, whereas the daily expected return is at this time at -0.4%. The volatility of related hype on Pure Bioscience is about 0.0%, with the expected price after the next announcement by competition of 0.05. Pure Bioscience currently holds 239 K in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Pure Bioscience has a current ratio of 1.98, which is within standard range for the sector. Debt can assist Pure Bioscience until it has trouble settling it off, either with new capital or with free cash flow. So, Pure Bioscience's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pure Bioscience sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pure to invest in growth at high rates of return. When we think about Pure Bioscience's use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next projected press release will be within a week. Check out Pure Bioscience Basic Forecasting Models to cross-verify your projections.

Pure Bioscience Related Hype Analysis

Pure Bioscience Additional Predictive Modules

Most predictive techniques to examine Pure price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pure using various technical indicators. When you analyze Pure charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Pure Bioscience stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pure Bioscience, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pure Bioscience based on analysis of Pure Bioscience hews, social hype, general headline patterns, and widely used predictive technical indicators.

When running Pure Bioscience's price analysis, check to measure Pure Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pure Bioscience is operating at the current time. Most of Pure Bioscience's value examination focuses on studying past and present price action to predict the probability of Pure Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pure Bioscience's price. Additionally, you may evaluate how the addition of Pure Bioscience to your portfolios can decrease your overall portfolio volatility.